CardioSignal
Provides world-leading solutions for the detection of complex and life-threatening cardiac conditions using its proprietary patent-protected technology, enabling fast and reliable cardiac analysis using just a regular smartphone.
Launch date
Employees
Market cap
-
Enterprise valuation
$40—60m (Dealroom.co estimates Jan 2024.)
Company register number 2800927-7
Turku Southwest Finland (HQ)
Authorizing premium user...